Dr. Enisa Shevroja is a resident and clinical researcher at the Interdisciplinary Center for Bone Diseases at Lausanne University Hospital (CHUV) in Lausanne, Switzerland. She has over 10 years of research experience in osteoporosis, with a particular focus on the clinical utility of Trabecular Bone Score (TBS) in diagnosis and management of osteoporosis. She completed her PhD on TBS, contributing to advancing its role in fracture risk assessment and treatment monitoring. Her research also explores opportunistic screening approaches, including applications in osteoporosis and sarcopenia, as well as AI-based models for fracture prediction. She has been involved in major projects funded by the Swiss National Science Foundation, further supporting innovation in skeletal health assessment and personalized patient care.